Key result
Rapid dyspnea and a unique pulmonary artery mass suggest rare primary pulmonary artery sarcoma.
Case Report (n=4)
No
Primary pulmonary artery sarcoma is a rare condition often misdiagnosed as chronic thromboembolic pulmonary hypertension, requiring high clinical suspicion when a unique mass presents with rapidly progressive symptoms.
Answers are grounded in this paper and cite their sources.
Raises suspicion for pulmonary artery sarcoma in atypical masses with rapid dyspnea; leaves open need for prospective validation.
Primary sarcoma of the pulmonary artery (PSPA) is extremely rare. Many cases are misdiagnosed as pulmonary arterial hypertension (PAH) because of chronic thromboembolic disease (CTD). Four cases of PSPA with the initial misdiagnosis are reported. The presence of a unique mass in the main pulmonary artery or proximal branches, rapidly progressive dyspnea, and constitutional symptoms should raise the suspicion of PSPA. The pathological diagnosis is usually confirmed during surgery, which is done along with adjuvant chemotherapy, the treatment of choice.
No takes yet. Share an insight, caveat, or question.
Fernández‐Golfín et al. (2008) conducted a case report in Primary sarcoma of the pulmonary artery (PSPA) (n=4). Surgery with adjuvant chemotherapy was evaluated. Four cases of primary pulmonary artery sarcoma highlight that a unique mass in the pulmonary artery with rapid dyspnea should raise suspicion for this rare condition.
Synapse has enriched 10 related papers. Consider them for comparative context: